The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

Danone has launched a drinkable yogurt product under its Oikos brand in the US which looks to target users of Ozempic and ...

Weight-loss drugs Mounjaro and Wegovy gain popularity among Indian diabetes patients. New research highlights rare but ...

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

The partnership means that Apple's fitness and wellness service will be made available to all members who enrol onto ...

Danone is launching Oikos Fusion, a dairy-based drink targeting U.S. consumers using weight loss medications like Wegovy.

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...